Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Aston Science secures 39.6 billion won in Series D funding, with Solidus as a new investor. The funds will aid in developing therapeutic cancer vaccines to boost patient immunity.

PRIVATESep 01, 2026•3 days ago

Amount Raised

₩39.6 Billion

Round Type

Series D

BiotechnologyVenture Capital

Investors

Solidus

Description

Aston Science has closed a Series D funding round amounting to 39.6 billion won, supported by new investor Solidus. The biotech company focuses on therapeutic cancer vaccines that activate immune responses against malignant cells. This funding will accelerate the development of its lead pipeline, AST-301, currently in Phase 2 trials. Key results from these trials are anticipated next month.

Company Information

Company

Aston Science

About

Solidus Investment is a biotech-focused venture capital firm that specializes in deploying capital to a range of biotech firms with diverse technological capabilities. Recently acquired by JW Holdings, Solidus aims to leverage expertise in investment and validation to discover promising biotechnology companies and enhance its open innovation framework. The firm focuses on small molecules, antibodies, and targeted protein degradation technologies in its investments.

Don't miss Aston Science's next move

Get an email the moment Aston Science raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Aston Science's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Aston Science raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.